OTCMKTS:PURE - Pure Bioscience Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$0.40 0.00 (0.00 %)
(As of 04/25/2019 04:25 AM ET)
Previous Close$0.40
Today's Range$0.40 - $0.41
52-Week Range$0.2905 - $0.8850
Volume3,725 shs
Average Volume23,031 shs
Market Capitalization$29.65 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.11
PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. It manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection and formulates with other compounds. The company offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a food contact surface sanitizer and disinfectant; PURE Control, a food contact processing aid for fresh produce and raw poultry; PURE Multi-Purpose and Floor Cleaner Concentrate used to clean various resilient surfaces, including floors, glass, and food contact surfaces; and PURE Multi-Purpose Hi-Foam Cleaner Concentrate used to clean stainless steel equipment, resilient floors, walls, and painted surfaces. Its SDC-based disinfecting and sanitizing products comprising Axen30, a hard surface disinfectant; Axenohl, an antimicrobial formulation used as a raw material ingredient in the manufacturing of consumer and commercial disinfecting and sanitizing products; and SILVÉRION, an antimicrobial solution used against bacteria, viruses, yeast, and molds. It sells its products to distributors and end users. PURE Bioscience, Inc. was founded in 1992 and is headquartered in El Cajon, California.

Receive PURE News and Ratings via Email

Sign-up to receive the latest news and ratings for PURE and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Miscellaneous chemical products
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:PURE
CUSIPN/A
Phone619-596-8600

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.77 million
Book Value$0.02 per share

Profitability

Net Income$-7,440,000.00
Net Margins-368.45%

Miscellaneous

Employees9
Market Cap$29.65 million
Next Earnings Date6/12/2019 (Estimated)
OptionableNot Optionable

Pure Bioscience (OTCMKTS:PURE) Frequently Asked Questions

What is Pure Bioscience's stock symbol?

Pure Bioscience trades on the OTCMKTS under the ticker symbol "PURE."

How were Pure Bioscience's earnings last quarter?

Pure Bioscience, Inc. (OTCMKTS:PURE) posted its quarterly earnings data on Wednesday, March, 6th. The company reported ($0.02) earnings per share (EPS) for the quarter. The firm earned $0.39 million during the quarter. Pure Bioscience had a negative return on equity of 426.49% and a negative net margin of 368.45%. View Pure Bioscience's Earnings History.

When is Pure Bioscience's next earnings date?

Pure Bioscience is scheduled to release their next quarterly earnings announcement on Wednesday, June 12th 2019. View Earnings Estimates for Pure Bioscience.

Has Pure Bioscience been receiving favorable news coverage?

News headlines about PURE stock have trended somewhat negative recently, according to InfoTrie Sentiment Analysis. The research firm rates the sentiment of press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Pure Bioscience earned a daily sentiment score of -1.0 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 1.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the next several days.

Who are some of Pure Bioscience's key competitors?

What other stocks do shareholders of Pure Bioscience own?

Who are Pure Bioscience's key executives?

Pure Bioscience's management team includes the folowing people:
  • Mr. Henry R. Lambert, CEO, Sec. & Director (Age 68)
  • Mr. Mark Stuart Elliott, VP of Fin. (Age 44)
  • Mr. Thomas Richard Myers, Chief Operating Officer (Age 67)
  • Ms. Bridget C. Tinsley-Cormier M.S., Sr. VP of Technology & Bus. Devel. and VP of Market Devel.

How do I buy shares of Pure Bioscience?

Shares of PURE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Pure Bioscience's stock price today?

One share of PURE stock can currently be purchased for approximately $0.40.

How big of a company is Pure Bioscience?

Pure Bioscience has a market capitalization of $29.65 million and generates $1.77 million in revenue each year. The company earns $-7,440,000.00 in net income (profit) each year or ($0.11) on an earnings per share basis. Pure Bioscience employs 9 workers across the globe.

What is Pure Bioscience's official website?

The official website for Pure Bioscience is http://www.purebio.com.

How can I contact Pure Bioscience?

Pure Bioscience's mailing address is 1725 GILLESPIE WAY, EL CAJON CA, 92020. The company can be reached via phone at 619-596-8600.


MarketBeat Community Rating for Pure Bioscience (OTCMKTS PURE)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  80 (Vote Outperform)
Underperform Votes:  76 (Vote Underperform)
Total Votes:  156
MarketBeat's community ratings are surveys of what our community members think about Pure Bioscience and other stocks. Vote "Outperform" if you believe PURE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PURE will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/25/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel